Concurrent Mantle Cell Lymphoma and Paraneoplastic Membranous Nephropathy [0.03%]
伴发套细胞淋巴瘤和副肿瘤性膜性肾病病例报告
Daoyuan Lv,Ping Sun,Yuanyuan Li et al.
Daoyuan Lv et al.
We report a rare case of synchronous stage IV mantle cell lymphoma (MCL) and paraneoplastic membranous nephropathy (MN) in a 48-year-old man. The patient presented with a nasopharyngeal mass; biopsy confirmed cyclin D1-positive MCL harborin...
Case Reports
Kidney medicine. 2026 Apr 27;8(7):101372. DOI:10.1016/j.xkme.2026.101372 2026
Evolving Comorbidity Burden and Clinical Characteristics in Peritoneal Dialysis: A 17-Year Nationwide Study [0.03%]
日本全国范围内腹膜透析患者的合并症负担和临床特征变化的17年研究
Anne-Sophie Lavedrine,Annabel Boyer,Thierry Lobbedez et al.
Anne-Sophie Lavedrine et al.
Rationale & objective: Peritoneal dialysis (PD) is a home-based kidney replacement therapy for patients with kidney failure associated with numerous benefits, but it remains underused. As chronic kidney disease becomes a ...
Association of Smoking, Smoking Cessation, and Genetic Susceptibility With Chronic Kidney Disease Risk [0.03%]
吸烟、戒烟与遗传易感性对慢性肾脏病风险的影响关联研究
Zhiyi Chen,Duo Lv,Xin Huang et al.
Zhiyi Chen et al.
Rationale & objectives: Chronic kidney disease (CKD) is a major public health issue, and smoking is a key modifiable risk factor. This study aimed to assess the associations of smoking and smoking cessation with incident ...
Raymond Vanholder,Dina Abdellatif,Augusto Cesar Soares Dos Santos Jr et al.
Raymond Vanholder et al.
The current kidney care model-focused on late-stage disease and in-center hemodialysis-is unsustainable, because of costs, environmental burden, poor outcomes, and reduced quality of life. The 78th World Health Assembly's recognition of kid...
A Scoping Review of Toolkits Addressing Ethical Issues in Health Registry and Clinical Research Enrollment Among African Americans With CKD [0.03%]
针对美国黑人CKD患者群体卫生登记和临床研究招募中的伦理问题的工具包的范围回顾性评价
Henry Asante Antwi,Adaeze Aroh,Deidra C Crews et al.
Henry Asante Antwi et al.
Chronic kidney disease (CKD) disproportionately affects African Americans, yet they remain underrepresented in health registries and clinical research enrollment. This scoping review maps and describes existing toolkits designed to address ...
Cardiorenal Syndrome and Depressive Symptoms: Exploring the Mood-Kidney Link With Heart Failure Risk in a Post-hoc Analysis of SPRINT [0.03%]
心脏肾综合征和抑郁症状：对SPRINT研究的事后分析中探讨情绪与肾脏联系的心力衰竭风险
Sydney E Hartsell,Stavros G Drakos,Robert E Boucher et al.
Sydney E Hartsell et al.
Rationale & objective: Depression is a potential pathophysiologic pathway in type 4 cardiorenal syndrome, ie chronic kidney disease (CKD) resulting in chronic heart failure (HF). We investigated whether depressive symptom...
The Changing Landscape of Peritoneal Dialysis in America: A Facility-Level Analysis of Growth [0.03%]
美国腹膜透析格局的变化：基于机构水平的增长分析
Ankur D Shah,Sandipan Shringi,Afzal Ariff et al.
Ankur D Shah et al.
Rationale & objective: Peritoneal dialysis (PD) use has expanded nationwide, yet it is unclear whether this growth reflects more facilities initiating PD programs, expansion of existing programs, or both. We sought to des...
Comparable Efficacy of Medium Cut-Off Dialysis Plus HA130 Hemoadsorption and Postfilter Hemodiafiltration in Removing Protein-Bound Uremic Toxins [0.03%]
中 cuts-off 血液透析联合HA130血液吸附与后稀释式血液滤过清除蛋白结合型尿毒症毒素的效果可比性研究
Gonzalo Ramírez-Guerrero,Cristian Pedreros-Rosales,María José Cáceres et al.
Gonzalo Ramírez-Guerrero et al.
Rationale & objective: Protein-bound uremic toxins, including indoxyl sulfate and p-cresyl sulfate, are poorly removed by conventional dialysis and contribute to cardiovascular, inflammatory, and neurological complication...
I-131 Use in Patients With Kidney Failure Receiving Dialsyis: Therapeutic Challenges and Evidence From Literature [0.03%]
肾衰竭透析患者使用碘化碘(I-131)的治疗挑战及文献证据
Abhirami Das,Zachary Peckham,Byron May et al.
Abhirami Das et al.
Radioactive iodine (131I) therapy is widely used in the treatment of differentiated thyroid cancer and hyperthyroidism. However, its use in patients with kidney failure treated with hemodialysis presents unique challenges due to impaired re...
Case Reports
Kidney medicine. 2026 May 13;8(7):101407. DOI:10.1016/j.xkme.2026.101407 2026
Dihydropyridine Calcium Channel Blocker Therapy and Risk of CKD Progression in Type 2 Diabetes Treated With Renin Angiotensin System Inhibitors and SGLT2 Inhibitors: A Real-World Retrospective Cohort Study [0.03%]
二氢吡啶型钙离子通道阻滞剂治疗对伴有1型糖尿病且接受肾素血管紧张素系统抑制剂和SGLT2抑制剂治疗的CKD患者病情进展的影响：一项真实世界回顾性队列研究
Timna Agur,Tali Steinmetz,Shira Goldman et al.
Timna Agur et al.
Rationale & objective: Optimal antihypertensive therapy with renoprotective effects is essential to slow diabetic kidney disease progression. We evaluated the impact of dihydropyridine calcium channel blockers on kidney o...